Polygenic Risk Scores Show Distinct Genetic Architectures of IBD-Associated Comorbidities

Area of Science:

• Genetics
• Gastroenterology
• Immunology

Background:

• Patients with inflammatory bowel disease (IBD) exhibit a higher incidence of immune and non-immune comorbidities.
• The underlying reasons, whether shared genetic susceptibility or chronic inflammation, remain unclear.

Purpose of the Study:

• To systematically assess the genetic risk underlying 20 IBD-comorbidity associations.
• To investigate the role of shared genetic architecture versus other factors in IBD comorbidity patterns.

Main Methods:

• Utilized polygenic risk scores (PRS) in 853 IBD patients and 4333 controls.
• Employed a clumping-and-thresholding approach for PRS generation.
• Performed logistic regression analysis adjusted for covariates and applied Bonferroni correction.

Main Results:

• IBD patients showed significantly higher genetic risk for colorectal cancer, primary sclerosing cholangitis, and celiac disease.
• Conversely, lower genetic risk was observed for depression and atopic dermatitis.
• Dose-response patterns were noted for genetically mediated comorbidities, with Crohn's disease patients having higher PRS for specific conditions.

Conclusions:

• IBD comorbidities display selective, not uniform, genetic overlap.
• Findings suggest involvement of epithelial-immune related loci, but PRS alone cannot infer causality.
• Further research is needed to elucidate the contributions of inherited risk, inflammation, and environmental factors.